SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
SGMT

Sagimet Biosciences Inc. (NASDAQ:SGMT)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$9.08-$0.54 (-5.61%)
 
Market cap
$648M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 14, 2023
Market Cap$648.02M+36.1%
Revenue (ttm)$0
Net Income-$53.32M+7.5%
EPS-$1.19+33.1%
Shares Out71.37M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,501,037
Open$9.22
Previous Close$9.62
Day's Range$8.89 - $9.22
52-Week Range$4.50 - $11.45
Beta3.47
AnalystsBuy
Price Target$21.40(+135.68%)
Earnings DateMar 10, 2027

About SGMT

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company’s lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Address
155 Bovet Road, San Mateo, CA, 94402, US
Market Cap
648 million
Employees
16
Industrial Classification
Biotechnology

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$4.91M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
5 Buy0 Hold0 SellAvg target $18.00 (+98.2%)

5 firms rating SGMT in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Fair
From SGMT’s reported statements · Q3 2026 (trailing 12 months) · 4 of 5 pillars

Next catalysts

1 Day
-5.61%
5 Days
-10.10%
1 Month
-8.74%
6 Months
+28.07%
1 Year
+36.13%

$SGMT stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in SGMT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by SGMT's directors and management

Net Shares Purchased by Insiders−500k−250k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

SGMT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New SGMT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to SGMT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in SGMT

VTIVanguard Morningstar Total Stock Market ETF$16.58M
IWMiShares Russell 2000 ETF$14.45M
XBIState Street SPDR S&P Biotech ETF$12.46M
VXFVanguard Extended Market ETF$7.01M
IWOiShares Russell 2000 Growth ETF$4.24M
IBBiShares Biotechnology ETF$4.04M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from SGMT’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
99
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
10
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

DWASInvesco Dorsey Wright SmallCap Momentum ETF0.39%
ISMDInspire Small/Mid Cap ETF0.22%
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.19%
IWCiShares Micro-Cap ETF0.16%
BMEDiShares Health Innovation Active ETF0.14%
XBIState Street SPDR S&P Biotech ETF0.14%
FTKIFirst Trust Small Cap BuyWrite Income ETF0.07%
VFMOVanguard U.S. Momentum Factor ETF0.04%
IBBiShares Biotechnology ETF0.04%
IBBQInvesco Nasdaq Biotechnology ETF0.04%
IWOiShares Russell 2000 Growth ETF0.04%
PWSPacer WealthShield ETF0.03%

Weight is the stock’s share of each fund’s holdings.